252 related articles for article (PubMed ID: 27078005)
1. Cicatrizing Conjunctivitis in a Patient Diagnosed With Drug Reaction With Eosinophilia and Systemic Symptoms/Drug-Induced Hypersensitivity Syndrome but With Features of Stevens-Johnson Syndrome.
Bohm KJ; Ciralsky JB; Harp JL; Bajaj S; Sippel KC
Cornea; 2016 Jun; 35(6):888-91. PubMed ID: 27078005
[TBL] [Abstract][Full Text] [Related]
2. Incidence, presenting features, and diagnosis of cicatrising conjunctivitis in the United Kingdom.
Radford CF; Rauz S; Williams GP; Saw VP; Dart JK
Eye (Lond); 2012 Sep; 26(9):1199-208. PubMed ID: 22722485
[TBL] [Abstract][Full Text] [Related]
3. Updates on the immunopathology and genomics of severe cutaneous adverse drug reactions.
Gibson A; Deshpande P; Campbell CN; Krantz MS; Mukherjee E; Mockenhaupt M; Pirmohamed M; Palubinsky AM; Phillips EJ
J Allergy Clin Immunol; 2023 Feb; 151(2):289-300.e4. PubMed ID: 36740326
[TBL] [Abstract][Full Text] [Related]
4. Paracetamol (Acetaminophen)-associated SJS, TEN, AGEP, and DRESS Syndromes - A Narrative Review.
Pakkir Maideen NM; Barakat IR; Jumale AH
Curr Drug Saf; 2024; 19(2):218-223. PubMed ID: 37151075
[TBL] [Abstract][Full Text] [Related]
5. Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis.
Hama N; Abe R; Gibson A; Phillips EJ
J Allergy Clin Immunol Pract; 2022 May; 10(5):1155-1167.e5. PubMed ID: 35176506
[TBL] [Abstract][Full Text] [Related]
6. Antiepileptic Medication-induced Severe Cutaneous Adverse Reactions in Hospitalized Children: A Retrospective Study.
Abtahi-Naeini B; Makhmali R; Amini N; Reza Maracy M; Nouri N; Momen T
Iran J Allergy Asthma Immunol; 2024 Apr; 23(2):139-148. PubMed ID: 38822509
[TBL] [Abstract][Full Text] [Related]
7. Severe cutaneous adverse reactions associated with the immune checkpoint inhibitors: A case/non-case analysis using the Food and Drug Administration Adverse Event Reporting System.
Godfrey H; Jedlowski P; Thiede R
Australas J Dermatol; 2024 May; 65(3):243-253. PubMed ID: 38572842
[TBL] [Abstract][Full Text] [Related]
8. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis.
Wei BM; Fox LP; Kaffenberger BH; Korman AM; Micheletti RG; Mostaghimi A; Noe MH; Rosenbach M; Shinkai K; Kwah JH; Phillips EJ; Bolognia JL; Damsky W; Nelson CA
J Am Acad Dermatol; 2024 May; 90(5):885-908. PubMed ID: 37516359
[TBL] [Abstract][Full Text] [Related]
9. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and management.
Wei BM; Fox LP; Kaffenberger BH; Korman AM; Micheletti RG; Mostaghimi A; Noe MH; Rosenbach M; Shinkai K; Kwah JH; Phillips EJ; Bolognia JL; Damsky W; Nelson CA
J Am Acad Dermatol; 2024 May; 90(5):911-926. PubMed ID: 37516356
[TBL] [Abstract][Full Text] [Related]
10. Overlapping Stevens-Johnson Syndrome and DRESS Syndrome Caused by Phenobarbital: A Vietnamese Case Report.
Van Nguyen K; Van Vu Q; Tran MH; Nguyen HQ; Le CQ; Dang BCT; Chu HC; Van Nguyen D
Glob Pediatr Health; 2023; 10():2333794X231216556. PubMed ID: 38073663
[TBL] [Abstract][Full Text] [Related]
11. Analysis of clinical features of oxcarbazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis.
Yan Q; Liu X; Lei H; Liu R; Hu Y
Front Med (Lausanne); 2023; 10():1232969. PubMed ID: 37881633
[TBL] [Abstract][Full Text] [Related]
12. A case of drug-induced hypersensitivity syndrome complicated with fulminant type 1 diabetes and type 2 myocardial infarction.
Kobayashi Y; Adachi T; Arakawa H; Minakata Y; Yajima K; Inazumi T
J Dermatol; 2023 Dec; 50(12):1603-1607. PubMed ID: 37563935
[TBL] [Abstract][Full Text] [Related]
13. An observational study of severe cutaneous adverse reactions at a tertiary care teaching hospital.
Lekshmipriya K; Pradeesh A; Vasudevan B; Dash M; Sood A; Gera V
Med J Armed Forces India; 2023 Dec; 79(Suppl 1):S209-S216. PubMed ID: 38144617
[TBL] [Abstract][Full Text] [Related]
14. Medication Associations With Severe Cutaneous Adverse Reactions: A Case/Non-Case Analysis Using the FDA Adverse Event Reporting System.
Godfrey H; Jedlowski P; Thiede R
J Cutan Med Surg; 2024; 28(1):51-58. PubMed ID: 38189282
[TBL] [Abstract][Full Text] [Related]
15. Phenytoin Induced Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome: A Clinical Case Report.
Varghese A; Alosious A; Thomas R; Surendran K; Vilapurathu JK
J Pharm Pract; 2024 Feb; 37(1):225-228. PubMed ID: 35924976
[TBL] [Abstract][Full Text] [Related]
16. Clinical Characteristics and Treatment of Ophthalmic Sequelae of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis at a Tertiary Eyecare Centre in Hungary.
Tóth G; Lukács A; Stachon T; Schirra F; Sándor GL; Nagy ZZ; Szentmáry N
Ophthalmol Ther; 2024 May; 13(5):1343-1356. PubMed ID: 38507192
[TBL] [Abstract][Full Text] [Related]
17. DRESS and Stevens-Johnson Syndrome Overlap Secondary to Allopurinol in a 50-Year-Old Man-A Diagnostic and Treatment Challenge: Case Report.
Martínez JD; Franco R; Sáenz LM; Alvarado AG; García JA; Delgado SM; Ionescu MA; Busilă C; Tatu AL
Life (Basel); 2023 Nov; 13(12):. PubMed ID: 38137852
[TBL] [Abstract][Full Text] [Related]
18. Topical Betamethasone Treatment of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis with Ocular Involvement in the Acute Phase.
Matsumoto K; Ueta M; Inatomi T; Fukuoka H; Mieno H; Tamagawa-Mineoka R; Katoh N; Kinoshita S; Sotozono C
Am J Ophthalmol; 2023 Sep; 253():142-151. PubMed ID: 37182731
[TBL] [Abstract][Full Text] [Related]
19. The Role of Frozen Section in the Rapid Diagnosis of Severe Cutaneous Adverse Drug Reactions.
Nicholas R; Bindra MS; Mathew L; Sathishkumar D; Lakshmanan J; George R
Indian Dermatol Online J; 2021; 12(1):78-83. PubMed ID: 33768026
[TBL] [Abstract][Full Text] [Related]
20. Severe cutaneous adverse reactions in a tertiary care center in Jamaica.
McNish AJS; Ho JD; East-Innis ADC
JAAD Int; 2024 Jun; 15():139-146. PubMed ID: 38545494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
